Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy

Medicine (United States)

Volumn 95, Issue 36, 2016, Pages

  Jung, Su Young ^a   Kim, Hyunwook ^a   Park, Seohyun ^a   Jhee, Jong Hyun ^a   Yun, Hae Ryong ^a   Kim, Hyoungnae ^a   Kee, Youn Kyung ^a   Yoon, Chang Yun ^a   Oh, Hyung Jung ^a   Chang, Tae Ik ^b   Park, Jung Tak ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a   Lee, Hajeong ^c   Kim, Dong Ki ^c   Han, Seung Hyeok ^a  

^a Yonsei University   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Acute kidney injury (AKI); Continuous renal replacement therapy (CRRT); Electrolyte; Mineral

Indexed keywords

ELECTROLYTE; MINERAL; PHOSPHATE; TRACE ELEMENT;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR DISEASE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MORTALITY RISK; PHOSPHATE BLOOD LEVEL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ADVERSE EFFECTS; AGED; BLOOD; COMPLICATION; EPIDEMIOLOGY; MORTALITY; PROCEDURES; RENAL REPLACEMENT THERAPY; SEPSIS; SOUTH KOREA;

ACUTE KIDNEY INJURY; AGED; ELECTROLYTES; FEMALE; HUMANS; HYPERPHOSPHATEMIA; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; REPUBLIC OF KOREA; SEPSIS; TRACE ELEMENTS;

EID: 84988448981     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004542     Document Type: Article

References (51)

1. Majumdar A. Sepsis-induced acute kidney injury. Indian J Crit Care Med 2010;14:14-21.
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6.
3. Case J, Khan S, Khalid R, et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013;2013:479730.
4. Samimagham HR, Kheirkhah S, Haghighi A, et al. Acute kidney injury in intensive care unit: incidence, risk factors and mortality rate. Saudi J Kidney Dis Transpl 2011;22:464-70.
5. Kerr M, Bedford M, Matthews B, et al. The economic impact of acute kidney injury in England. Nephrol Dial Transplant 2014;29:1362-8.
6. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-70.
7. Garg AX, Parikh CR. Yin and Yang: acute kidney injury and chronic kidney disease. J Am Soc Nephrol 2009;20:8-10.
8. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-23.
9. Ronco C, Kellum JA, Bellomo R, et al. Potential interventions in sepsisrelated acute kidney injury. Clin J Am Soc Nephrol 2008;3:531-44.
10. Adekola OO, Soriyan OO, Meka I, et al. The incidence of electrolyte and acid-base abnormalities in critically ill patients using point of care testing (i-STAT portable analyser). Nig Q J Hosp Med 2012;22:103-8.
11. Lee CT, Guo HR, Chen JB. Hyponatremia in the emergency department. Am J Emerg Med 2000;18:264-8.
12. Shiber JR, Mattu A. Serum phosphate abnormalities in the emergency department. J Emerg Med 2002;23:395-400.
13. Joannidis M. Continuous renal replacement therapy in sepsis and multisystem organ failure. Semin Dial 2009;22:160-4.
14. Giuliani C, Peri A. Effects of hyponatremia on the brain. J Clin Med 2014;3:1163-77.
15. Efstratiadis G, Sarigianni M, Gougourelas I. Hypomagnesemia and cardiovascular system. Hippokratia 2006;10:147-52.
16. Al-Shoha M, Klair JS, Girotra M, et al. Magnesium toxicity-induced ileus in a postpartum patient treated for preeclampsia with magnesium sulphate. ACG Case Rep J 2015;2:227-9.
17. Park JT, Lee H, Kee YK, et al. High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 2016;doi: 10. 1053/j. ajkd. 2016. 02. 049. Epub 2016 Apr 12.
18. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
19. Bellomo R, Ronco C, Kellum JA, et al. Acute dialysis quality initiative w. acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-212.
20. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
21. Tsagalis G. Update of acute kidney injury: intensive care nephrology. Hippokratia 2011;15:53-68.
22. Claure-Del Granado R, Bouchard J. Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management. Blood Purif 2012;34:186-93.
23. Statland H. A fluid and electrolyte balance service for clinical use. J Am Med Assoc 1952;150:771-2.
24. Hessels L, Hoekstra M, Mijzen LJ, et al. The relationship between serum potassium, potassium variability and in-hospital mortality in critically ill patients and a before-after analysis on the impact of computer-assisted potassium control. Crit Care 2015;19:4.
25. Suzuki S, Egi M, Schneider AG, et al. Hypophosphatemia in critically ill patients. J Crit Care 2013;28:536. e9-19.
26. Bech A, Blans M, Raaijmakers M, et al. Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume. J Crit Care 2013;28:838-43.
27. Shah SR, Tunio SA, Arshad MH, et al. Acute kidney injury recognition and management: a review of the literature and current evidence. Glob J Health Sci 2015;8:49202.
28. Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977;137:203-20.
29. Shor R, Halabe A, Rishver S, et al. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006;36:67-72.
30. Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM 2010;103:449-59.
31. Martinez MJ, Martinez MA, Montero M, et al. Hypophosphatemia in postoperative patients with total parenteral nutrition: influence of nutritional support teams. Nutr Hosp 2006;21:657-60.
32. Paterson CR, Naismith KI, Young JA. Severe unexplained hypophosphatemia. Clin Chem 1992;38:104-7.
33. Davis SV, Olichwier KK, Chakko SC. Reversible depression of myocardial performance in hypophosphatemia. Am J Med Sci 1988; 295:183-7.
34. Bollaert PE, Levy B, Nace L, et al. Hemodynamic andmetabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 1995;107:1698-701.
35. O'Connor LR, Wheeler WS, Bethune JE. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med 1977;297:901-3.
36. Saglikes Y, Massry SG, Iseki K, et al. Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat. Am J Physiol 1985;248:F93-99.
37. Craddock PR, Yawata Y, VanSanten L, et al. Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med 1974;290:1403-7.
38. Brunelli SM, Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol 2007;18:1999-2003.
39. Schiffl H, Lang SM. Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury. Int Urol Nephrol 2013;45:191-7.
40. Yang Y, Zhang P, Cui Y, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 2013;17:R205.
41. Demirjian S, Teo BW, Guzman JA, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011; 26:3508-14.
42. Aziz M, Jacob A, Wang P. Revisiting caspases in sepsis. Cell Death Dis 2014;5:e1526.
43. Roderburg C, Benz F, Cardenas DV, et al. Persistently elevated osteopontin serum levels predict mortality in critically ill patients. Crit Care 2015;19:271.
44. Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets-an updated view. Mediators Inflamm 2013;2013:165974.
45. Hirsiger S, Simmen HP, Werner CM, et al. Danger signals activating the immune response after trauma. Mediators Inflamm 2012;2012:315941.
46. Lau WL, Pai A, Moe SM, et al. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis 2011;18:105-12.
47. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007;167:879-85.
48. Papa S, Skulachev VP. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997;174:305-19.
49. McGovern AP, de Lusignan S, van Vlymen J, et al. Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One 2013;8:e74996.
50. Silva AP, Fragoso A, Pinho A, et al. Phosphorus as an early marker of morbidity and mortality in type 2 chronic kidney disease diabetic patients. J Diabetes Complications 2013;27:328-32.
51. O'Seaghdha CM, Hwang SJ, Muntner P, et al. Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 2011;26:2885-90.